Exploring Public Perspectives on Mitochondrial Disease and Donation – RBMO
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn about a paper by Ezra Kneebone et al. published in RBMO:
“Mitochondrial disease can affect any organ or tissue in the body, at any age, with varying severity. Mild cases of mitochondrial disease can present as fatigue and exercise intolerance, whereas severe cases can be life threatening. In Australia, where this study is set, one baby is born each week with a severe form of mitochondrial disease. There is currently no cure, and treatment consists of symptom management.
The findings of this new survey study indicate that the Australian public is largely supportive of mitochondrial donation’s clinical implementation, if shown to be safe in the clinical trial program that is currently progressing. The challenge, explained by the authors, is ensuring adequate understanding of complex and controversial technologies to arrive at confident conclusions about public acceptability. To address this, this study provided participants with information about the technology and then assessed their views in this representative survey. The findings indicate that the Australian public has low levels of knowledge about mitochondrial disease and mitochondrial donation, but once informed, are supportive of it.
Published open access, the paper can be read in full for free from our in-press articles section now.”
Title: Public support for mitochondrial donation: an Australian knowledge and attitudes study
Authors: Ezra Kneebone, Zachary Russell, Ainsley J. Newson, Chris Degeling, Karinne Ludlow, Narelle Warren, Catherine Mills
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic